-
Security Type
-
Crowd SAFE
-
Min Investment
-
$100
-
Location
-
TRABUCO CANYON, CA
-
Offering Date
-
October 17, 2022
-
Expected Close Date
-
February 03, 2023
-
Target Raise
-
$25.00K-$1.24M
-
No. Investors
-
228
-
Security Price
-
$1
- Number of Employees
- 5
- Cash
- $297,216
- Revenue
- $0
- Short Term Debt
- $7,872
- Cost of Goods
- $0
- Long Term Debt
- $290,000
- Net Income
- $-62,494
Company Description
NovaXS has created a smart needle-free injection system that simplifies the medication self-administration process and improves remote treatment outcome, allowing patients to draw the medications from the vial, expel the air bubble in the cartridge, varify the dosage volume, administer the medications and track treatment progress with one simple click on the device.
Perks
Reserve
$1,500
Receive
15-minute call with the founders
Reserve
$5,000
Receive
Quarterly investor update
Reserve
$10,000
Receive
Invitation to our private technology showcase event in 2023
Key Deal Facts
Needle-free drug delivery, ease of use, remote treatment adherence tracking
Wide indications, including infertility, diabetes, allergies & more
Now finalizing prototypes | Targeting commercial launch in Q2 2024
Secured strategic partnerships with Pharmas and Healthcare Systems
Filed 4 intellectual properties to protect the technology
Backed by Baxter, Edward-Elmhurst Health, mHUB, Courtyard Ventures & more
Featured by Forbes, TechCrunch, MassDevice, UChicago and UC Berkeley
Management Team / Advisory Board Bios
Alina Su
Founder & CEO
Harvard Medical School PhD candidate; Medical Device Inventor
Jonathan Xing
Co-founder & COO
Booth MBA Candidate; Serial Entrepreneur with Successful Exit
Alex Zou
Co-founder & Chief Technology Advisor
UC Berkeley Electroengineering PhD Candidate; Industrial Designer
Reed McCalmon
CFO
10+ years experience in biotech finance
Sean McKibben
VP, Doctor Relations
Former President at Mount Carmel Hospital and University Hospitals; Entrepreneur in Medical Device
Haley Titus, PhD
VP, Clinical Operations
Northwestern University Neurology PhD; 10+ Experience in Clinical Study Design
Shuhua Zhang
Software Lead
5+ Year Experience in Software Development; Developer with Entrepreneurial Experience
Irina Conboy, PhD
Board Advisor
Bioengineering Professor at UC Berkeley; Regenerative Medicine Pioneer
David Harrell
Board Advisor
Former Founder & CEO at OptimizeRX
Frederic Zussa
Board Advisor
Former Director of Corporate Strategy & Innovation at Pfizer
James Wetrich
Board Advisor
Former President at Reapplix
